[OncoHost in Labiotech.eu] OncoHost to launch PROphet for non-small cell lung cancer in the U.S. in 2023

Interview with Ofer Sharon.

Ofer Sharon is the CEO of OncoHost, a biotech company in the precision oncology space. A physician by training, Sharon has leveraged his experience in pharma drug development and entrepreneurship to lead OncoHost through the development of PROphet, the company’s host response profiling platform, which will launch in the U.S. for non-small cell lung cancer (NSCLC) patients in February 2023.

Read more here.